CD28 and systemic lupus erythematosus: This has been observed in humans, where T cells from patients with SLE express higher levels of the PRL receptor than those from healthy subjects; upon activation with anti-CD3/CD28 plus PRL, increased IFNγ secretion is only observed in the T cells of patients with SLE [34].